Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000026

President and CEO sold 50,000 shares at an average $102.67 ($5,133,442)

  • President and CEO acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Meeker David P · President and CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-14 Exercise or conversion : show line 1 in the form 10b5-1 +50,000 $6.05 $302,500 289,258 D
2026-09-14 Sale : show line 2 in the form 10b5-1 −6,439 $101.75 $655,145 282,819 D
2026-09-14 Sale : show line 3 in the form 10b5-1 −30,746 $102.35 $3,146,761 252,073 D
2026-09-14 Sale : show line 4 in the form 10b5-1 −8,698 $103.43 $899,634 243,375 D
2026-09-14 Sale : show line 5 in the form 10b5-1 −1,817 $104.55 $189,965 241,558 D
2026-09-14 Sale : show line 6 in the form 10b5-1 −2,300 $105.19 $241,937 239,258 D
Open-market sales · 50,000 sh · avg $102.67 · $5,133,442

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-14 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Buy) −50,000 15,431 D
Loading xslF345X06/form4.xml…